Document Actions
CytoViva’s Nanoscale Imaging Among ”Most Promising” at Rice Forum
Houston-based CytoViva Inc., an emerging leader in high-performance, nanoscale imaging, was named one of the Top 10 “most promising” life science companies during the 2008 Rice Alliance for Technology & Entrepreneurship Life Science Venture Forum held in May.
The event attracted more than 350 executives from all sectors of life sciences – investors, venture capitalists, industry representatives, business leaders, advisors/mentors, service providers, and entrepreneurs.
CytoViva has developed a high-performance optical imaging system for nanoscale research, which allows life science and materials researchers to image sub-100 nanometer particles and materials ‘live’ and in ‘real time,’ said Chuck Ludwig, CytoViva’s president. The company is also currently introducing a proprietary Hyperspectral Imaging (HSI) capability, which will measure the unique spectral signatures of imaged samples and allow researchers to positively and quantitatively identify the nano-particles and materials imaged with CytoViva.
“We are very excited about our ability to combine two elegant technologies –the CytoViva imaging system and HSI – into a comprehensive research tool. This award recognizes the value of this system in both biotech and nanotech research and development.” Ludwig added.
About Rice’s Award and Event
The list of “Most Promising” Life Science Companies was chosen from nearly 40 competitors and judged by the Rice Alliance Information Technology Advisory Board. Presentations from the firms were based on an “elevator pitch” overview presentation, which simulates meeting an investor on an elevator and having only 90 seconds to convince them to invest in your company.
Rice Alliance Director Brad Burke said of the event, “Every year the quality of companies improves. Many of the companies at this year’s event have developed prototypes, obtained proven results and are on their second round of funding. This makes them more appealing to investors, who have also expressed appreciation for the quality of the companies.”
"This Rice Alliance Life Science Venture Forum has been a great venue to showcase some of the most promising life science technology-based ventures which have the potential to dramatically improve the lives of millions of patients. We are pleased to encourage the commercialization of technology innovations through this program, " said Chris Capelli, Vice President, Office of Technology Commercialization at the U.T. M. D. Anderson Cancer Center.
Since the Rice Alliance Life Sciences Venture Forum began seven years ago, the MD Anderson Cancer Center has co-hosted and supported it, Capelli noted, adding, “The event is aligned with our mission at the Office of Technology Commercialization to move our most promising innovations out of the lab and into the clinic and marketplace to aid M. D. Anderson Cancer Center in fulfilling its mission of Making Cancer History.”
Elevator pitches from the competition can be heard at www.businessmakersradioshow.com.
CytoViva has developed a high-performance optical imaging system for nanoscale research, which allows life science and materials researchers to image sub-100 nanometer particles and materials ‘live’ and in ‘real time,’ said Chuck Ludwig, CytoViva’s president. The company is also currently introducing a proprietary Hyperspectral Imaging (HSI) capability, which will measure the unique spectral signatures of imaged samples and allow researchers to positively and quantitatively identify the nano-particles and materials imaged with CytoViva.
“We are very excited about our ability to combine two elegant technologies –the CytoViva imaging system and HSI – into a comprehensive research tool. This award recognizes the value of this system in both biotech and nanotech research and development.” Ludwig added.
About Rice’s Award and Event
The list of “Most Promising” Life Science Companies was chosen from nearly 40 competitors and judged by the Rice Alliance Information Technology Advisory Board. Presentations from the firms were based on an “elevator pitch” overview presentation, which simulates meeting an investor on an elevator and having only 90 seconds to convince them to invest in your company.
Rice Alliance Director Brad Burke said of the event, “Every year the quality of companies improves. Many of the companies at this year’s event have developed prototypes, obtained proven results and are on their second round of funding. This makes them more appealing to investors, who have also expressed appreciation for the quality of the companies.”
"This Rice Alliance Life Science Venture Forum has been a great venue to showcase some of the most promising life science technology-based ventures which have the potential to dramatically improve the lives of millions of patients. We are pleased to encourage the commercialization of technology innovations through this program, " said Chris Capelli, Vice President, Office of Technology Commercialization at the U.T. M. D. Anderson Cancer Center.
Since the Rice Alliance Life Sciences Venture Forum began seven years ago, the MD Anderson Cancer Center has co-hosted and supported it, Capelli noted, adding, “The event is aligned with our mission at the Office of Technology Commercialization to move our most promising innovations out of the lab and into the clinic and marketplace to aid M. D. Anderson Cancer Center in fulfilling its mission of Making Cancer History.”
Elevator pitches from the competition can be heard at www.businessmakersradioshow.com.